Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Medtech 360 | US | 2016

The US EP mapping and ablation device market will experience strong growth through 2024, particularly in the diagnostic and ablation catheter segments, largely as a result of rising ablation volumes.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2034, driven by the rapid expansion of AF ablation procedures and the coinciding uptake of PFA devices, which…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…